Fortress Transportation and Infrastructure Investors LLC Announces 2015 K-1 Tax Package
Mar 29, 2016 20:14 pm UTC| Business
NEW YORK, March 29, 2016 -- Fortress Transportation and Infrastructure Investors LLC (“FTAI”) today announced that its 2015 Schedule K-1 tax packages are now available online. FTAI shareholders may access their Schedule...
Aptose Reports Fourth Quarter and Year End 2015 Results
Mar 29, 2016 20:10 pm UTC| Business
SAN DIEGO and TORONTO, March 29, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...
Heritage Oaks Bancorp Schedules First Quarter Conference Call
Mar 29, 2016 20:10 pm UTC| Business
PASO ROBLES, Calif., March 29, 2016 -- Heritage Oaks Bancorp, (Nasdaq:HEOP), the holding company of Heritage Oaks Bank, will host a conference call on Friday, April 29, 2016 at 8:00 a.m. Pacific Time to discuss its...
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results
Mar 29, 2016 20:07 pm UTC| Business
CAMBRIDGE, Mass., March 29, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today reported financial results for the three months and...
Mar 29, 2016 20:05 pm UTC| Business
HOUSTON, March 29, 2016 -- Spark Energy, Inc. (NASDAQ:SPKE), a Delaware corporation (“Spark”), announced today the launch of an underwritten secondary public offering of 1.5 million shares of its Class A common stock...
Landec Corporation Reports Third Quarter and Nine Months Fiscal 2016 Results
Mar 29, 2016 20:05 pm UTC| Business
MENLO PARK, Calif., March 29, 2016 -- Landec Corporation (NASDAQ:LNDC), a leading developer and marketer of innovative and proprietary products for healthy living applications in the food and biomedical markets,...
CymaBay Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 29, 2016 20:05 pm UTC| Business
NEWARK, Calif., March 29, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today...